Alteco Medical Past Earnings Performance

Past criteria checks 0/6

Alteco Medical has been growing earnings at an average annual rate of 5.6%, while the Medical Equipment industry saw earnings growing at 22.9% annually. Revenues have been declining at an average rate of 6.7% per year.

Key information

5.6%

Earnings growth rate

11.8%

EPS growth rate

Medical Equipment Industry Growth6.2%
Revenue growth rate-6.7%
Return on equity-121.4%
Net Margin-221.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Have Insiders Been Buying Alteco Medical AB (NGM:ALTE) Shares?

Jan 11
Have Insiders Been Buying Alteco Medical AB (NGM:ALTE) Shares?

The Chairman of Alteco Medical AB (NGM:ALTE), Anders Althin, Just Bought 50% More Shares

Jan 11
The Chairman of Alteco Medical AB (NGM:ALTE), Anders Althin, Just Bought 50% More Shares

Revenue & Expenses Breakdown

How Alteco Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NGM:ALTE Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 243-771
30 Jun 243-781
31 Mar 246-681
31 Dec 236-691
30 Sep 236-691
30 Jun 236-7101
31 Mar 235-8101
31 Dec 228-6101
30 Sep 229-4101
30 Jun 2210-291
31 Mar 2210-281
31 Dec 218-491
30 Sep 219-492
30 Jun 219-592
31 Mar 218-692
31 Dec 208-792
30 Sep 206-892
30 Jun 207-8101
31 Mar 206-9111
31 Dec 196-8110
30 Sep 196-9102
30 Jun 195-10113
31 Mar 198-8113
31 Dec 188-9123
30 Sep 187-9125
30 Jun 187-9124
31 Mar 184-14125
31 Dec 175-13124
30 Sep 175-13121
30 Jun 175-13121
31 Mar 175-10111
31 Dec 165-9111
30 Sep 166-7101
30 Jun 167-6110
31 Mar 168-7120
31 Dec 158-7120
30 Sep 156-9121
30 Jun 156-9111
31 Mar 156-9102
31 Dec 146-8102
30 Sep 147-691
30 Jun 147-791
31 Mar 148-591

Quality Earnings: ALTE is currently unprofitable.

Growing Profit Margin: ALTE is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ALTE is unprofitable, but has reduced losses over the past 5 years at a rate of 5.6% per year.

Accelerating Growth: Unable to compare ALTE's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ALTE is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (31%).


Return on Equity

High ROE: ALTE has a negative Return on Equity (-121.35%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 04:23
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Alteco Medical AB is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution